UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF
DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-36333
| Bio-Path Holdings, Inc. |
| (Exact name of registrant as specified in its charter) |
625 Stanwix St. #2407, Pittsburgh,
Pennsylvania 15222
(630) 708-0750
(Address, including zip code,
and telephone number, including area code, of registrant’s principal executive offices)
Common and Preferred Stock
(Title of each class of securities
covered by this Form)
Please place an X in the box(es)
to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) |
☒ |
| Rule 12g-4(a)(2) |
☐ |
| Rule 12h-3(b)(1)(i) |
☐ |
| Rule 12h-3(b)(1)(ii) |
☐ |
| Rule 15d-6 |
☐ |
| Rule 15d-22(b) |
☐ |
Approximate number of holders of record as of the certification
or notice date: 125
Pursuant to the requirements of the
Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
| Date: May 21, 2026 |
By: |
/s/ Vikram Grover |
| |
|
Chief Executive Officer |
